From: Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
Variable | SEARCH | ||
---|---|---|---|
Mean age (range) | 52.6 (24 to 73) | ||
Mean follow-up in years (range) | 8.5 (0.37 to 18.6) | ||
Number of breast cancer deaths (%) | 563 (14) | ||
Five-year survival % | 90 | ||
 | Categories | Number | Percent |
Grade | 1 | 768 | 19 |
 | 2 | 1, 622 | 39 |
 | 3 | 1, 020 | 25 |
 | Missing | 715 | 17 |
Node status | Negative | 2, 309 | 56 |
 | Positive | 1, 424 | 35 |
 | Missing | 392 | 10 |
Tumour size | < 2 cm | 2, 208 | 54 |
 | 2 to 4.9 cm | 1, 522 | 37 |
 | ≥5 cm | 145 | 4 |
 | Missing | 250 | 6 |
Endocrine therapy | No | 770 | 19 |
 | Yes | 3, 315 | 80 |
 | Missing | 40 | 1 |
Chemotherapy | No | 2, 692 | 65 |
 | Yes | 1, 392 | 34 |
 | Missing | 41 | 1 |
ER status | Negative | 772 | 19 |
 | Positive | 2, 287 | 55 |
 | Missing | 1, 066 | 26 |
PR status | Negative | 889 | 22 |
 | Positive | 2, 194 | 53 |
 | Missing | 1, 042 | 25 |
HER2 status | Negative | 2, 560 | 62 |
 | Positive | 349 | 8 |
 | Missing | 1, 216 | 29 |
Molecular subtype | Luminal 1a | 1, 631 | 40 |
 | Luminal 1b | 215 | 5 |
 | Luminal 2 | 202 | 5 |
 | HER2 | 120 | 3 |
 | CBP | 214 | 5 |
 | 5NP | 130 | 3 |
 | Missing | 1, 613 | 39 |